Farallon Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-150,697	Closed	-$2.01M	–	110
2019 Q4	$2.01M	Hold	150,697	–	–	0.02%	114
2019 Q3	$1.34M	Buy	150,697 +697	+0.5%	+$7.64K	0.01%	98
2019 Q2	$2.14M	Hold	150,000	–	–	0.02%	100
2019 Q1	$4.93M	Buy	150,000 +2,083	+1%	+$107K	0.04%	87
2018 Q4	$8.79M	Buy	147,917 +12,500	+9%	+$1.23M	0.08%	83
2018 Q3	$19M	Buy	135,417 +29,872	+28%	+$3.63M	0.13%	69
2018 Q2	$13M	Buy	+105,545	New	+$8.97M	0.1%	71
2016 Q3	–	Sell	-69,900	Closed	-$5.02M	–	70
2016 Q2	$5.02M	Hold	69,900	–	–	0.1%	56
2016 Q1	$5.6M	Buy	69,900 +15,000	+27%	+$1.18M	0.07%	68
2015 Q4	$4.14M	Buy	54,900 +35,625	+185%	+$5.72M	0.05%	62
2015 Q3	$7.39M	Buy	19,275 +108	+0.6%	+$48.7K	0.12%	66
2015 Q2	$7.96M	Buy	19,167 +8,334	+77%	+$3.49M	0.11%	70
2015 Q1	$5.15M	Buy	10,833 +5,833	+117%	+$2.77M	0.08%	79
2014 Q4	$1.85M	Hold	5,000	–	–	0.03%	82
2014 Q3	$1.18M	Buy	+5,000	New	+$1.13M	0.02%	81